PATENT CLAIM ANALYSIS

Application Number: 16178335
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "343000"]

Abstract:
The invention provides a potassium-competitive acid blocker (P-CAB) for use in the treatment, prevention and/or reduction of gastro-esophageal reflux disease (GERD) symptoms in patients who are partial responders to a proton pump inhibitor (PPI). The P-CAB may, for example, be selected from 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine (vonoprazan), revaprazan (YH1855), YH4808, RQ-4 and CS-526, or a salt thereof.

Claim (Index 11):
The method of  claim 10 , wherein the PPI is dexlansoprazole, esomeprazole, or a salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13383056', '11574393', '11574408', '12442277', '11574398']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7864643415647268
- 35 USC 102 Novelty (BERT): 0.5376331197040609
- Combined Prediction Score: 0.7615812193786602
- Mean Citation Score: 273.973496
- Max Citation Score: 376.30676
- Similarity Product: 192.58058537795543

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test